|
|
Article: Other News To Note.(Aureon Laboratories Inc. president Robert Shovlin)(Bavarian Nordic A/S small pox vaccine Imvamune)(GenVec Inc.)
- Article from:
- BIOWORLD Today
- Article date:
- August 26, 2009
CopyrightCOPYRIGHT 2009 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Aureon Laboratories Inc., of Yonkers, N.Y., promoted Robert Shovlin to president and CEO. Shovlin, who joined Aureon in June 2005, most recently served as the company's president and chief operating officer. Former CEO Vijay Aggarwal will step down, though he will remain a member of the board.
Bavarian Nordic AS, of Kvistgaard, Denmark, said it is in negotiations with the U.S. government to develop a freeze-dried version of its small pox vaccine, Imvamune.
Cellceutix Corp., of Beverly, Mass., acquired rights to the compound KM 732, a small molecule developed in a company-affiliated laboratory in Pune, India. The compound, which demonstrated a ...